Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Denali Therapeutics Inc.
Business Segments
Business Segments
Research and Development Expense
Research and Development Expense
Denali Therapeutics Inc.
·
Business Segments
·
1 segment
·
Rolls up to
R&D
Breakdown
Segments
Business Segments
View metric
Watchlist
Screener
Filings
Earnings
Charts
Quarterly
Annual
TTM
Segment
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Q2 '26
Business Segments
$116.23M
$102.7M
$101.95M
$97.91M
$103.85M
$97.02M
Total
$116.23M
$102.7M
$101.95M
$97.91M
$103.85M
$97.02M
